Centerpoint Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63K | Hold |
900
| – | – | 0.02% | 144 |
|
|
2025
Q1 | $66K | Hold |
900
| – | – | 0.02% | 146 |
|
|
2024
Q4 | $59K | Hold |
900
| – | – | 0.02% | 157 |
|
|
2024
Q3 | $70K | Hold |
900
| – | – | 0.02% | 149 |
|
|
2024
Q2 | $70K | Buy |
900
+780
| +650% | +$60.7K | 0.03% | 151 |
|
|
2024
Q1 | $8K | Hold |
120
| – | – | ﹤0.01% | 334 |
|
|
2023
Q4 | $8K | Sell |
120
-170
| -59% | -$11.3K | ﹤0.01% | 334 |
|
|
2023
Q3 | $20K | Hold |
290
| – | – | 0.01% | 223 |
|
|
2023
Q2 | $21K | Sell |
290
-335
| -54% | -$24.3K | 0.01% | 235 |
|
|
2023
Q1 | $43K | Buy |
+625
| New | +$43K | 0.02% | 173 |
|
|
2022
Q3 | – | Sell |
-10
| Closed | -$1K | – | 386 |
|
|
2022
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 340 |
|
|
2022
Q1 | $1K | Buy |
10
+1
| +11% | +$100 | ﹤0.01% | 348 |
|
|
2021
Q4 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 361 |
|
|
2018
Q3 | – | Sell |
-564
| Closed | -$20K | – | 247 |
|
|
2018
Q2 | $20K | Buy |
+564
| New | +$20K | 0.02% | 140 |
|